Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

A 333-unit community, Hillcrest Apartments, will be developed directly across from Amgen’s headquarters in Thousand Oaks, ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

MK-0616, an experimental oral medication aimed at reducing LDL cholesterol, is intended to be the first oral PCSK9 inhibitor.

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

The University of Maryland School of Medicine (UMSOM) is pleased to formally acknowledge the 11 newest members of its Board of Visitors, who have joined the board over the past two academic years.

AI partners Microsoft and OpenAI’s cooling relationship cools further with Amgen’s switch from Copilot to ChatGPT.

JLL Capital Markets secured $182M in construction financing & equity for Latigo Group's 333-unit Hillcrest Apartments in ...

Despite investing tens of billions of dollars into OpenAI, Microsoft is still, apparently, competing with its business ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...